|
IXHL
|
Incannex Healthcare Limited
|
US
|
NASDAQ
|
|
NVOS
|
Novo Integrated Sciences, Inc.
|
US
|
NASDAQ
|
|
SNPX
|
Synaptogenix, Inc.
|
US
|
NASDAQ
|
|
TENX
|
Tenax Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NEU
|
Neuren Pharmaceuticals Ltd
|
AU
|
ASX
|
|
BIEI
|
Premier Biomedical
|
US
|
OTC
|
|
BRCTF
|
Bioarctic Ab
|
US
|
OTC
|
|
NOXOF
|
Noxopharm Limited
|
US
|
OTC
|
|
NURPF
|
Neuren Pharmaceutica
|
US
|
OTC
|
|
WSNAF
|
Wesana Health Holdings Inc
|
US
|
OTC
|
|
KALY
|
Kalytera Therapeutics Inc
|
CA
|
TSXV
|
|
NRX
|
NurExone Biologic Inc
|
CA
|
TSXV
|
|
IQI
|
Incannex Healthcare Ltd
|
DE
|
F
|
|
290660
|
Neofect Co.Ltd
|
KR
|
KQ
|
|
ABLI
|
Abliva AB
|
SE
|
ST
|
|
BIOA-B
|
BioArctic AB (publ)
|
SE
|
ST
|
|
IRRAS
|
Irras AB
|
SE
|
ST
|
|
07X
|
ANNOVIS BIO INC. DL-0001
|
DE
|
F
|